GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) » Definitions » Owner Earnings per Share (TTM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Owner Earnings per Share (TTM) : 47.51 (As of Mar. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Torrent Pharmaceuticals Owner Earnings per Share (TTM)?

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Torrent Pharmaceuticals's Owner Earnings per Share (TTM) ended in Mar. 2023 was ₹47.51. It's Price-to-Owner-Earnings ratio for today is 54.99.


The historical rank and industry rank for Torrent Pharmaceuticals's Owner Earnings per Share (TTM) or its related term are showing as below:

NSE:TORNTPHARM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.21   Med: 39.07   Max: 75.18
Current: 54.99


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Torrent Pharmaceuticals was 75.18. The lowest was 10.21. And the median was 39.07.


NSE:TORNTPHARM's Price-to-Owner-Earnings is ranked worse than
78.9% of 417 companies
in the Drug Manufacturers industry
Industry Median: 27.13 vs NSE:TORNTPHARM: 54.99

Torrent Pharmaceuticals's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was ₹13.10. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹44.16. It's PE Ratio ratio for today is 59.16.

Torrent Pharmaceuticals's EPS without NRI for the three months ended in Dec. 2023 was ₹11.27. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was ₹41.62. It's PE Ratio without NRI ratio for today is 62.78.


Torrent Pharmaceuticals Owner Earnings per Share (TTM) Historical Data

The historical data trend for Torrent Pharmaceuticals's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torrent Pharmaceuticals Owner Earnings per Share (TTM) Chart

Torrent Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.18 22.09 32.14 19.53 47.51

Torrent Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 47.51 - - -

Competitive Comparison of Torrent Pharmaceuticals's Owner Earnings per Share (TTM)

For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torrent Pharmaceuticals's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Torrent Pharmaceuticals's Price-to-Owner-Earnings falls into.



Torrent Pharmaceuticals Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Torrent Pharmaceuticals's Owner Earnings per Share (TTM) Calculation:

Last Year Average of Last 5 Years
Net Income 12,452
Depreciation, Depletion and Amortization 7,020
Change In Deferred Tax 0
5Y Average of Maintenance Capital Expenditure 3,212
Change In Working Capital -182
Shares Outstanding (Diluted Average) 338

1. Start with "Net Income" from income statement. Torrent Pharmaceuticals's Net Income for the trailing twelve months (TTM) ended in Mar. 2023 was ₹12,452 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Torrent Pharmaceuticals's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in Mar. 2023 was ₹7,020 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Torrent Pharmaceuticals's Change In Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2023 was ₹0 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = ₹3,212 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous year. If the revenue decreased from the previous year, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous year, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Torrent Pharmaceuticals's 5-Year Average Maintenance Capital Expenditure = ₹3,212 Mil

5. "Change In Working Capital" is from cashflow statement. Torrent Pharmaceuticals's Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2023 was ₹-182 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Torrent Pharmaceuticals's Shares Outstanding (Diluted Average) for the months ended in Mar. 2023 was 338.445 Mil.

Torrent Pharmaceuticals's Onwer Earnings Per Share for Mar. 2023 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( 12452.3 +7020.3+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-3212.1062+-182)/338.445
=47.51

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=2612.55/47.51
=54.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Torrent Pharmaceuticals Owner Earnings per Share (TTM) Related Terms

Thank you for viewing the detailed overview of Torrent Pharmaceuticals's Owner Earnings per Share (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Torrent Pharmaceuticals (NSE:TORNTPHARM) Business Description

Traded in Other Exchanges
Address
Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. It operates through Generic Formulation Business segments. Geographically, the business activities are carried out across Indian and International markets.

Torrent Pharmaceuticals (NSE:TORNTPHARM) Headlines

No Headlines